$REPH np - Broadfin Capital reported that it reduced its stake in Recro Pharma (REPH unch) to 15.31% from 16.21%. https...

Sorry about that, didn't transfer as I expected. Here are the top Institutional Holders as of 12/31/16 with more than 1...

$WINT LONGA list of institutional investors in WINTBroadfin Capital, LLC 8.25 777,797 0 0% 863.35 0.00 12...

AVIR: Wonderful buying opportunity $AVIR AH swing trade, VAPENDAVIR results against human rhinovirus 2-3 weeks. ++ Reput...

Broadfin Capital ups anty in REPH. http://www.insidermonkey.com/blog/healthcare-expert-kevin-kotler-boosts-his-stake-in...

glenn, it is hard to believe that this private placement is not having a bigger impact on the $REPH stock price. $REPH...

jimbecker on BIOTECH IN A Dr. KSS-LESS WORLD / Apr 23, 3:48pm

I bought 100 of $CAPR shares at the market. It was the only way to get the price down for you folks to enter at a better...

Elliot on Tetchy on Tekmira: Time to Short this RNAi Play? / Sep 27, 10:55am

Hi all, Cheers to ESPR, CTIX, RDUS, AGIO and others that have seen nice gains over the past couple of weeks. Sadly, I ...

newby3867 on Is This Red-Hot New “Blood Stock” Any Bloody Good as an Investment? / Jun 23, 12:45pm

OXBT getting real interesting to me at these levels if you have a long term horizon.Note the new buy in recently from Br...

fsgdu77077 on Of Needles, Haystacks, and the Needle-in-a-Haystack Cancer Diagnostics Nanocap That May Belong in Your Portfolio / Jun 13, 2:32pm

RE REPH: Broadfin Capital owns 8.2% and Sabby Management 3%. Interesting....